Clinical Research Directory
Browse clinical research sites, groups, and studies.
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Sponsor: AstraZeneca
Summary
This is a Phase II, open-label, multi-drug, multi-centre study designed to assess the efficacy, safety, tolerability, pharmacokinetics, and immunogenicity of novel combination therapies in participants with locally advanced unresectable or metastatic gastric or GEJ adenocarcinoma.
Official title: An Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
163
Start Date
2023-01-16
Completion Date
2029-05-31
Last Updated
2026-03-18
Healthy Volunteers
No
Conditions
Interventions
Rilvegostomig
an anti PD-1 and anti-TIGIT bispecific antibody; IV infusion
Volrustomig
an anti PD-1 and anti CTLA-4 bispecific antibody; IV infusion
FOLFOX
5-fluorouracil oxaliplatin, leucovorin (levoleucovorin when locally preferred and available)
XELOX
capecitabine and oxaliplatin
AZD0901
an anti Claudin18.2 ADC; IV infusion
5-Fluorouracil
5-FU, IV infusion
Capecitabine
Oral take
Locations (44)
Research Site
Los Angeles, California, United States
Research Site
Los Angeles, California, United States
Research Site
Baton Rouge, Louisiana, United States
Research Site
Grand Rapids, Michigan, United States
Research Site
New Hyde Park, New York, United States
Research Site
New York, New York, United States
Research Site
New York, New York, United States
Research Site
New York, New York, United States
Research Site
Shirley, New York, United States
Research Site
The Bronx, New York, United States
Research Site
Pittsburgh, Pennsylvania, United States
Research Site
Beijing, China
Research Site
Hangzhou, China
Research Site
Hangzhou, China
Research Site
Harbin, China
Research Site
Hefei, China
Research Site
Kunming, China
Research Site
Wuhan, China
Research Site
Yinchuan, China
Research Site
Zhengzhou, China
Research Site
Chūōku, Japan
Research Site
Kashiwa, Japan
Research Site
Sunto-gun, Japan
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Barcelona, Spain
Research Site
Elche(Alicante), Spain
Research Site
L'Hospitalet de Llobregat, Spain
Research Site
Madrid, Spain
Research Site
Madrid, Spain
Research Site
Santander, Spain
Research Site
Hsinchu, Taiwan
Research Site
Kaohsiung City, Taiwan
Research Site
Taichung, Taiwan
Research Site
Tainan, Taiwan
Research Site
Taipei, Taiwan
Research Site
Taipei, Taiwan
Research Site
Taoyuan District, Taiwan
Research Site
Edinburgh, United Kingdom
Research Site
Leeds, United Kingdom
Research Site
London, United Kingdom
Research Site
Oxford, United Kingdom